{"id":623,"date":"2019-02-20T12:26:56","date_gmt":"2019-02-20T11:26:56","guid":{"rendered":"https:\/\/bogenommedicinskcannabis.dk\/?page_id=623"},"modified":"2019-02-26T21:17:55","modified_gmt":"2019-02-26T20:17:55","slug":"medicinsk-cannabis-lindrer-symptomer-paa-adfaerdsmaessige-lidelser","status":"publish","type":"page","link":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/artikler\/cannabis-og-autisme\/medicinsk-cannabis-lindrer-symptomer-paa-adfaerdsmaessige-lidelser\/","title":{"rendered":"Medicinsk cannabis lindrer symptomer p\u00e5 adf\u00e6rdsm\u00e6ssige lidelser"},"content":{"rendered":"<p>Brug af cannabinoider og CBD til disse patienter er af voksende interesse p\u00e5 de sociale medier. Mens data for disse indikationer er begr\u00e6nset til case rapporter med brug af Dronabinol (syntetisk THC), kan nogle af de fordele ved CBD p\u00e5 adf\u00e6rd og motoriske f\u00e6rdigheder, som tidligere blev omtalt i retrospektive studier af epilepsi, m\u00e5ske overf\u00f8res til denne patientgruppe.<\/p>\n<p>En 6-\u00e5rig dreng med tidlig b\u00f8rneautisme fik dr\u00e5ber af Dronabinol op til 3,62 mg dagligt. Han havde forbedring af sin hyperaktivitet, irritabilitet, sl\u00f8vhed, stereotype og tale.<a href=\"#_ftn1\" name=\"_ftnref1\">[1]\u00a0<\/a>Dronabinol markedsf\u00f8res ogs\u00e5 under navnet Marinol.<\/p>\n<p>I et publiceret abstract rapporterer Kruger et al. om effekten af Dronabinol som behandling af selvskadeadf\u00e6rd hos 10 mentalt retarderede unge.<a href=\"#_ftn2\" name=\"_ftnref2\">[2]<\/a> Dronabinol dosen rangerede fra 2,5 mg 2 x dagligt til 5 mg 4 x dagligt. 7 af de 10 patienter havde signifikante forbedringer af deres selvskadende adf\u00e6rd, som varede i hele opf\u00f8lgningen ved 6 m\u00e5neder. 2 af de 10 patienter oplevede ophidselse og behandlingen blev afbrudt.<\/p>\n<p>Et israelsk single-center dobbelt-blindet, placebo-kontrolleret cross-over fors\u00f8g med CBD og THC i en blanding p\u00e5 20:1 mod adf\u00e6rdsproblemer hos b\u00f8rn med autisme skal starte i januar 2017.<a href=\"#_ftn3\" name=\"_ftnref3\">[3]<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-624\" src=\"https:\/\/bogenommedicinskcannabis.dk\/wp-content\/uploads\/2019\/02\/marinol.jpg\" alt=\"\" width=\"450\" height=\"400\" srcset=\"https:\/\/bogenommedicinskcannabis.dk\/wp-content\/uploads\/2019\/02\/marinol.jpg 450w, https:\/\/bogenommedicinskcannabis.dk\/wp-content\/uploads\/2019\/02\/marinol-300x267.jpg 300w\" sizes=\"auto, (max-width: 450px) 100vw, 450px\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"#_ftnref1\" name=\"_ftn1\">[1]<\/a> \u00a0Kurz R, Blass K.\u00a0Use of dronabinol (delta-9-THC) in autism: a prospective single-case-study with an early infantile autistic child.\u00a0<em>Cannabinoids<\/em>. 2010;\u00a05(\u00a04): 4\u2013 6. <a href=\"http:\/\/irka.org.rs\/wp-content\/uploads\/2014\/09\/Use-of-dronabinol-delta-9-THC-in-autism.pdf\">http:\/\/irka.org.rs\/wp-content\/uploads\/2014\/09\/Use-of-dronabinol-delta-9-THC-in-autism.pdf<\/a><br \/>\n<a href=\"#_ftnref2\" name=\"_ftn2\">[2]<\/a> Kruger T, Christophersen E.\u00a0An open label study of the use of dronabinol (marinol) in the management of treatment-resistant self-injurious behavior in 10 retarded adolescent patients.\u00a0<em>J Dev Behav Pediatr<\/em>. 2006;27(\u00a05): 433.<br \/>\n<a href=\"#_ftnref3\" name=\"_ftn3\">[3]<\/a> <a href=\"http:\/\/clinicaltrials.gov\/\">ClinicalTrials.gov<\/a>\u00a0[Internet]. Cannabinoids for behavioral problems in children with ASD (CBA). Updated November 2016. Cited November 6, 2016.\u00a0<a href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02956226\">https:\/\/www.clinicaltrials.gov\/ct2\/show\/<\/a><a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02956226\">NCT02956226<\/a>. Accessed March 19, 2017.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Brug af cannabinoider og CBD til disse patienter er af voksende interesse p\u00e5 de sociale medier. Mens data for disse indikationer er begr\u00e6nset til case rapporter med brug af Dronabinol (syntetisk THC), kan nogle af de fordele ved CBD p\u00e5 &hellip; <a href=\"https:\/\/bogenommedicinskcannabis.dk\/index.php\/artikler\/cannabis-og-autisme\/medicinsk-cannabis-lindrer-symptomer-paa-adfaerdsmaessige-lidelser\/\">L\u00e6s resten <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":643,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-623","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/comments?post=623"}],"version-history":[{"count":1,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/623\/revisions"}],"predecessor-version":[{"id":625,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/623\/revisions\/625"}],"up":[{"embeddable":true,"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/pages\/643"}],"wp:attachment":[{"href":"https:\/\/bogenommedicinskcannabis.dk\/index.php\/wp-json\/wp\/v2\/media?parent=623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}